Effect of erythropoietin on the content of lipid peroxidation products in lymphocytes in experimental thermal injury

Cover Page

Cite item


Aim. To investigate the effect of different concentrations of erythropoietin on the content of lipid peroxidation products in lymphocytes isolated from the blood of rats with thermal injury.

Methods. The study was performed on 22 white male rats. Thermal injury of IIIA degree on 4% of body surface area was simulated by immersion in water at a temperature of 98-99 °C. After 24 hours, blood lymphocytes were isolated and the content of the primary (diene conjugates), secondary (ketodienes and conjugated trienes) and final products (Schiff bases) of lipid peroxidation were determined spectrophotometrically. Erythropoietin was added to lymphocytes at concentrations of 0.01; 0.1 and 1 IU/ml.

Results. It was found that 24 hours after thermal injury there were the accumulation of primary, secondary and final products of lipid peroxidation in isopropanol fraction of lipid extracts of peripheral blood lymphocytes. Addition of erythropoietin to the rat lymphocytes resulted in a controversial change in the content of lipid peroxidation products: an increase in the heptane fraction, decrease - in the isopropanol fraction of lipid extract of lymphocytes. In the heptane fraction erythropoietin (at concentrations of 0.01, 0.1, and 1 IU/ml) increased the content of primary, end (at a concentration of 0.1 IU/ml) and secondary (at a concentration of 1 IU/ml) lipid peroxidation products. In isopropanol fraction erythropoietin reduced the content of primary (at concentrations of 0.01, 0.1, and 1 IU/ml), final (at concentrations of 0.01 and 0.1 IU/ml) and secondary (at concentrations of 0.01 and 1 IU/ml) products of lipid peroxidation.

Conclusion. It was found that there is an accumulation of lipid peroxidation products in the isopropanol fraction of lipid extract of lymphocytes isolated from peripheral blood of rats with thermal injury; erythropoietin application at concentrations of 0.01; 0.1 and 1 IU/ml increases the content of lipid peroxidation products in heptane fraction and decrease in the isopropanol fraction of lipid extract of lymphocytes.

About the authors

M V Osikov

South Ural State Medical University, Chelyabinsk, Russia

Author for correspondence.
Email: osaedgalina@mail.ru

E V Simonyan

South Ural State Medical University, Chelyabinsk, Russia

Email: osaedgalina@mail.ru

O T Saedgalina

South Ural State Medical University, Chelyabinsk, Russia

Email: osaedgalina@mail.ru


  1. Волчегорский И.А., Долгушин И.И., Колесников О.Л. и др. Экспериментальное моделирование и лабораторная оценка адаптивных реакций организма. - Челябинск: Изд-во ЧелГПУ, 2000. - 167 с.
  2. Дубинина Е.Е. Продукты метаболизма кислорода в функциональной активности клеток (жизнь и смерть, созидание и разрушение): физиологические и клинико-биохимические процессы. - СПб.: Медицинская пресса, 2006. - 400 с.
  3. Осиков М.В., Ахматов К.В., Федосов А.А. К вопросу о механизме влияния эритропоэтина на аффективный статус у больных хронической почечной недостаточностью, находящихся на гемодиализе // Фундамент. исслед. - 2012. - №7-1. - С. 140-145.
  4. Осиков М.В., Григорьев Т.А., Федосов А.А. и др. Эритропоэтин как регулятор экспрессии тромбоцитарных гликопротеинов // Соврем. пробл. науки и образования. - 2013. - №1. - URL: www.science-education.ru/107-7731 (дата обращения: 09.12.2014).
  5. Осиков М.В., Григорьев Т.А. Влияние эритропоэтина на активность систем плазменного протеолиза при экспериментальной почечной недостаточности // Бюлл. эксперим. биол. и мед. - 2012. - Т. 153, №1. - С. 27-30.
  6. Bohr S., Patel S.J., Shen K. Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns // Proc. Nat. Acad. Sci. - 2013. - Vol. 110, N 9. - P. 3513-3518. http://dx.doi.org/10.1073/pnas.1214099110
  7. Dang J., Jia R., Tu Y. Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level // Biomed. Pharmacotherap. - 2010. - Vol. 64, N 10. - P. 681-685. http://dx.doi.org/10.1016/j.biopha.2010.06.011
  8. Katavetin P., Tungsanga K., Eiam-Ong S. Antioxidative effects of erythropoietin // Kidney Int. Suppl. - 2007. - Vol. 107. - P. 10-15. http://dx.doi.org/10.1038/sj.ki.5002482
  9. Kim Y.J., Jung Y.W. Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain // Anat. Cell. Biol. - 2010. - Vol. 43, N 2. - P. 140-149. http://dx.doi.org/10.5115/acb.2010.43.2.140
  10. Meyer F.R.L., Steinborn R., Grausgruber H. at al. Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma // Veterinary J. - 2015. - Vol. 204, N 3. - P. 233-240. http://dx.doi.org/10.1016/j.tvjl.2015.06.003
  11. Parihar A., Parihar M.S., Milner S. Oxidative stress and anti-oxidative mobilization in burn injury // Burns. - 2008. - Vol. 34, N 1. - P. 6-17. http://dx.doi.org/10.1016/j.burns.2007.04.009
  12. Penn J.W., Grobbelaar A.O., Rolfe K.J. The role of the TGF-β family in wound healing, burns and scarring: a review // Intern. J. Burns Traum. - 2012. - Vol. 2, N 1. - P. 18-28.
  13. Ravat F., Payre J., Peslages P. at al. La brûlure: une pathologie inflammatoire // Pathol. Biol. - 2011. - Vol. 59, N 3. - P. 63-72. http://dx.doi.org/10.1016/j.patbio.2009.12.001
  14. Shalom A., Kramer E., Westreich M. Protective effect of human recombinant copper-zinc superoxide dismutase on zone of stasis survival in burns in rats // Ann. Plastic Surg. - 2011. - Vol. 66, N 6. - P. 607-609. http://dx.doi.org/10.1097/SAP.0b013e3181fc04e1
  15. Zhang J., Zhu Y., Zhou D. Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Nrf2-ARE pathway // Cytokine. - 2010. - Vol. 52, N 3. - P. 252-257. http://dx.doi.org/10.1016/j.cyto.2010.08.011

© 2015 Osikov M.V., Simonyan E.V., Saedgalina O.T.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies